Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baraldi

Showing results (1251-1260 of 1,515) with videos related to

Pageof 152
Sort By:
Plos One|August 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational ageIan P Keary, Roberto Ravasio, John R Fullarton, et al.
Journal of Medicinal Chemistry|March 21, 2003
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
European Journal of Dermatology : EJD|May 20, 2017
Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective studyEmi Dika, Giulia Maria Ravaioli, Pier Alessandro Fanti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 9, 2010
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatmentGaetano La Manna, Fabio Pizza, Elisa Persici, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Synthesis, radiolabeling, and preliminary biological evaluation of [3H]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl)-piperazine, a potent antagonist radioligand for the P2X7 receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, et al.
Environmental Pollution (Barking, Essex : 1987)|January 23, 2018
Seasonal variation of semen parameters correlates with environmental temperature and air pollution: A big data analysis over 6 yearsDaniele Santi, Elisa Magnani, Marco Michelangeli, et al.
Journal of Medicinal Chemistry|April 28, 2010
Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analoguesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Neurophotonics|January 3, 2017
Long-term continuous monitoring of the preterm brain with diffuse optical tomography and electroencephalography: a technical note on cap manufacturingAlfonso Galderisi, Sabrina Brigadoi, Simone Cutini, et al.
Anti-Cancer Drug Design|December 1, 1996
Synthesis, antiviral and antiproliferative activity of a new class of 5-(alkyl or arylthio)-6-vinyl uracilsP G Baraldi, B Cacciari, R Romagnoli, et al.
International Journal of Molecular Sciences|February 10, 2024
A Multi-Omics Approach Reveals Enrichment in Metabolites Involved in the Regulation of the Glutathione Pathway in LIN28B-Dependent Cancer CellsMatteo Stocchero, Diana Corallo, Silvia Bresolin, et al.
Pageof 152

Showing results (1251-1260 of 1,515) with videos related to

Sort By:
Pageof 152
Plos One|August 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational ageIan P Keary, Roberto Ravasio, John R Fullarton, et al.
Journal of Medicinal Chemistry|March 21, 2003
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
European Journal of Dermatology : EJD|May 20, 2017
Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective studyEmi Dika, Giulia Maria Ravaioli, Pier Alessandro Fanti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 9, 2010
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatmentGaetano La Manna, Fabio Pizza, Elisa Persici, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Synthesis, radiolabeling, and preliminary biological evaluation of [3H]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl)-piperazine, a potent antagonist radioligand for the P2X7 receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, et al.
Environmental Pollution (Barking, Essex : 1987)|January 23, 2018
Seasonal variation of semen parameters correlates with environmental temperature and air pollution: A big data analysis over 6 yearsDaniele Santi, Elisa Magnani, Marco Michelangeli, et al.
Journal of Medicinal Chemistry|April 28, 2010
Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analoguesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Neurophotonics|January 3, 2017
Long-term continuous monitoring of the preterm brain with diffuse optical tomography and electroencephalography: a technical note on cap manufacturingAlfonso Galderisi, Sabrina Brigadoi, Simone Cutini, et al.
Anti-Cancer Drug Design|December 1, 1996
Synthesis, antiviral and antiproliferative activity of a new class of 5-(alkyl or arylthio)-6-vinyl uracilsP G Baraldi, B Cacciari, R Romagnoli, et al.
International Journal of Molecular Sciences|February 10, 2024
A Multi-Omics Approach Reveals Enrichment in Metabolites Involved in the Regulation of the Glutathione Pathway in LIN28B-Dependent Cancer CellsMatteo Stocchero, Diana Corallo, Silvia Bresolin, et al.
Pageof 152